News UK medicines agency set to lose lucrative EMA work post-Brex... Agency already working on how to share post-Brexit workload.
News Brexit could delay drug launches, former MHRA chief warns Britain will be in "second or third tier" of drug launches, experts warn.
News Hunt under pressure over plans to quit EMA Britain could be in "second rank" of medicines access, warn MPs.
Views & Analysis Could the EMA really stay in London? After the UK voted to leave Europe, its seems obvious that the European Medicines Agency will have to leave London - but GSK’s Andrew Witty and others hope it might stay.
News Vtesse's rare disease drug set for UK early access Vtesse drug "promising" treatment for NPC disease, says regulator.
Views & Analysis Meeting pharmacovigilance standards in the US and Europe Examining statistics on recent inspections gives insight into the issues commonly faced.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
